During the past decade, British Columbia Cancer Agency conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 54 clinical trials were completed, i.e. on average, 80.6% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 24 clinical trials were completed. i.e. 104.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "British Columbia Cancer Agency" #1 sponsor was "British Columbia Cancer Agency" with 38 trials, followed by "NCIC Clinical Trials Group" with 30 trials sponsored, "Radiation Therapy Oncology Group" with 15 trials sponsored, "Hoffmann-La Roche" with 12 trials sponsored and "Pfizer" with 12 trials sponsored. Other sponsors include 139 different institutions and companies that sponsored additional 84 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "British Columbia Cancer Agency" #1 collaborator was "National Cancer Institute (NCI)" with 54 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "BC Cancer Foundation" with 6 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator and "Pfizer" with 5 trials as a collaborator. Other collaborators include 97 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "British Columbia Cancer Agency" are "Breast Cancer" (25 trials), "Lung Cancer" (20 trials), "Prostate Cancer" (20 trials), "Ovarian Cancer" (13 trials) and "Cancer" (7 trials). Many other conditions were trialed in "British Columbia Cancer Agency" in a lesser frequency.

Most popular intervention types in "British Columbia Cancer Agency" are "Drug" (192 trials), "Procedure" (35 trials), "Radiation" (34 trials), "Biological" (17 trials) and "Other" (17 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (19 trials), "Placebo" (15 trials), "quality-of-life assessment" (11 trials), "cisplatin" (10 trials) and "prednisone" (8 trials). Other intervention names were less common.

The vast majority of trials in "British Columbia Cancer Agency" are 177 trials for "All" genders, 44 trials for "Female" genders and 30 trials for "Male" genders.

Currently, there are NaN active trials in "British Columbia Cancer Agency". undefined are not yet recruiting, 19 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 168 completed trials in British Columbia Cancer Agency, 1 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in British Columbia Cancer Agency, 42 "Phase 1" clinical trials were conducted, 95 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 21 trials that are defined as “Not Applicable".

British Columbia Cancer Agency has several departments that took part in Clinical trials: "BCCA - Abbotsford Centre" - 26 trials, "BCCA-Centre for the North" - 10 trials, "BCCA-Vancouver Cancer Centre" - 294 trials, "BCCA - Cancer Centre for the Southern Interior" - 142 trials, "BCCA-Vancouver Island Cancer Centre" - 104 trials, "BCCA - Fraser Valley Cancer Centre" - 100 trials, "Nanaimo Cancer Clinic" - 6 trials